Head of global health R&D at Open Philanthropy, where he directs funding for vaccines, drugs and diagnostics aimed at diseases that get little commercial attention. He writes at blog.jacobtrefethen.com and co-hosts the Hard Drugs podcast with Saloni Dattani.
Jacob Trefethen did not write this page.
We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording.
Their own site.
Is this you? Claim it or ask us to remove it.Or tell us what is wrong here.
Their wordsThose are why I do not believe that AI could end disease within 10 years on its own, nor that 50-100 years of medical progress could occur 5-10 years after powerful AI due to AI progress alone
Their wordsRapid AI progress does not automatically mean rapid medical progress. If the point of AI progress is human flourishing, we must make other complementary investments too.
Their wordsInfectious diseases as a category receive vastly less R&D spending from industry than non-communicable diseases, per death they cause, because they disproportionately kill people in lower- and middle-income countries where the payoff for making a cure is less lucrative.